Evidence map›Paper›PMID 33022965›Full record

ArticleMolecules (Basel, Switzerland)2020

Aluminium Binding to Modified Amyloid-β Peptides: Implications for Alzheimer's Disease.

Cosmin Stefan Mocanu, Monica Jureschi, Gabi Drochioiu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. IBRO neuroscience reports · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Dietary supplements for prevention of Alzheimer's disease:Iranian journal of basic medical sciences · 2025
    Article
  7. Zeolite and Neurodegenerative Diseases.Molecules (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Cosmin Stefan MocanuFaculty of Chemistry, "Al. I. Cuza" University of Iasi, 11 Carol I, 70605 Iasi, Romania.
Monica JureschiFaculty of Chemistry, "Al. I. Cuza" University of Iasi, 11 Carol I, 70605 Iasi, Romania.
Gabi DrochioiuFaculty of Chemistry, "Al. I. Cuza" University of Iasi, 11 Carol I, 70605 Iasi, Romania.
Alexandru Ioan Cuza University · RO

Funding

Ministerul Cercetării şi Inovării 34PFE/19.10.2018
6 · The paper itself

Abstract

Aluminium (Al) is clearly neurotoxic and considerable evidence exists that Al may play a role in the aetiology or pathogenesis of Alzheimer's disease (AD). Nevertheless, the link between AD pathology and Al is still open to debate. Therefore, we investigated here the interaction of aluminium ions with two Aβ peptide fragments and their analogues. First, we synthesised by the Fmoc/

Indexed as

AluminumAlzheimer DiseaseAmino Acid SequenceAmyloid beta-PeptidesCircular DichroismHydrogen-Ion ConcentrationIonsMicroscopy, Atomic ForceModels, MolecularProtein BindingProtein ConformationProton Magnetic Resonance SpectroscopySpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSpectroscopy, Fourier Transform InfraredAluminumAmyloid beta-PeptidesIonsaluminium ionsAlzheimer’s diseaseamyloid-β peptidesatomic force microscopycircular dichroism spectroscopyFT-IRmass spectrometrymetal bindingmodified Aβ peptide fragments

Identifiers

PMID33022965
PMCPMC7582331
OpenAlexW3090761718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.